Matthew Mifsud, Vice Chair of Department of Otolaryngology – Head and Neck Surgery at University of South Florida, shared a post on LinkedIn:
“This weekend we hosted the USF ENT/TGH Cancer Institute 2025 Head and Neck Cancer Symposium in West Palm Beach.
We had a fantastic turnout of 45 attendees, and it was wonderful to see everyone so engaged in our presentations and tumor boards. During this event we reaffirmed the role of a multidisciplinary treatment approach for the management of complex head and malignancies. With recent data demonstrating the impact of neoadjuvant immunotherapy for upper aerodigestive tract malignancies, this was a very timely.
May thanks to my co-presenters for taking the time to travel across the state.
I also want to thank our amazing business development team for once again knocking it out of the park.”
More posts featuring Head and Neck Cancer.
